DEVLIN JODI (President, Therapeutics) received a stock award from TRISALUS LIFE SCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/25/2025ACC: 0001992151-25-000004
Officer· President, Therapeutics
Since Aug 2023
+150K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
150K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
98.9%
11/24/2025
50.57K→100.57K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/24/2025 | A · Award | +50K | — | — | 98.9% | 50.57K | 100.57K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
100K shares
Shares
+100K
Strike price
5.55
Held after
463.75K
Exercisable
—
11/24/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock100K shares | 11/24/2025 | A · Award | +100K | 5.55 | — | 463.75K |